Back to List View Graph View

Interleukin-6 (IL-6)

Interleukin-6 (IL-6) is a small secreted signaling protein — a pleiotropic cytokine of roughly 21–28 kDa, depending on glycosylation — produced by a wide range of cell types including T cells, B cells, monocytes and macrophages, fibroblasts, endothelial cells, and adipocytes.

Where the papers sit

26 papers from the last 6 months study Interleukin-6 (IL-6) directly · updated from PubMed 15 Nov 2026

  • Natural Anti-Inflammatory Therapies

    Natural products and traditional formulations dominate, with studies linking IL-6 and TNF-α to bone, liver, metabolic, ovarian, and wound-healing outcomes. JAK-STAT and Protein kinase B signaling recur as candidate mechanisms alongside antioxidant and anti-inflammatory effects. Network pharmacology and molecular docking generate targets that are then tested with biochemical or experimental assays. The work remains exploratory, with no consistent lead compound or clinical direction across diseases.

    8 papers · 30.8%

  • Inflammatory Cytokine Profiling

    Inflammatory cytokine panels are being used to characterize immune states in cancer, neurologic injury, intracranial hypertension, heart failure, melanoma, and cirrhosis. IL-6 is repeatedly interpreted alongside IL-10, TNF-α, IFN-γ, and other markers rather than as a standalone signal. Machine learning, immune-infiltration analysis, and WGCNA extend profiling toward molecular risk signatures. Simvastatin-associated IL-6 reduction provides a treatment signal, but the broader work remains descriptive and disease-specific.

    8 papers · 30.8%

  • IL-6 Biomarker Prediction

    IL-6, C-reactive protein, and procalcitonin are being evaluated as complementary markers for diagnosis, severity assessment, and prognosis. Receiver operating characteristic analyses emphasize sensitivity, specificity, and area under the curve in appendicitis, pediatric and neonatal sepsis, myocardial infarction, and cardiovascular outcomes. Longitudinal biomarker monitoring and multivariable models are favored over reliance on IL-6 alone. The evidence supports clinical risk stratification, while optimal thresholds and incremental value over routine markers remain unsettled.

    7 papers · 26.9%

  • Targeting IL-6 Inflammation

    IL-6-driven inflammation is being connected to epigenetic remodeling, cytokine-induced senescence, lymphoma dependence, and viral disease. In breast cancer, IL-1β and IL-6 cooperate with DNA methylation and histone changes, while CDK8/19 inhibitors offer a route against IL-6-dependent lymphoma. Biomimetic nanotherapy approaches instead seek to neutralize inflammatory signaling during SARS-CoV-2 infection. The shared direction is pathway interruption, but the mechanisms and therapeutic settings remain distinct.

    3 papers · 11.5%

NEW DIRECTION

IL-6 functions as a required endocrine signal for the systemic stress response to intense exercise

High-intensity interval exercise in healthy young men, with IL-6 signaling blocked by tocilizumab, showed that IL-6 was not merely an inflammatory marker: receptor blockade reduced epinephrine release by about half, lowered glucose and lactate responses, and selectively impaired mobilization of several immune-cell populations despite unchanged upstream HPA-axis hormones. This assigns IL-6 a necessary coordinating role in sympathoadrenal, metabolic, and immune responses to exercise, outside the set’s usual use of IL-6 as a disease-associated inflammatory biomarker or pathological mediator 42270042Jun.

NEW DIRECTION

IL-6 acts through placental stromal CD73 to promote leukemia-cell differentiation

Acute promyelocytic leukemia, human placental mesenchymal stem cells, and NB4 cells provided evidence that elevated IL-6 in patients was not only associated with risk stratification and retinoic acid syndrome severity: IL-6 increased CD73 expression in stromal cells, enabling those cells to enhance ATRA-induced NB4 differentiation, with CD73 inhibition or knockdown testing that dependency. This gives IL-6 a stromal, pro-differentiation role in treatment response rather than the biomarker or inflammatory-pathway role used by the other papers 42528120Jul.

Papers

The 26 papers from the last 6 months that study Interleukin-6 (IL-6) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Natural Anti-Inflammatory Therapies (8)
  1. Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
  2. Evaluation of the Role of Interleukin 6 in Paget's Disease of Bone. Calcified tissue international · 3 Sept 2026 PMID 42687003
  3. Network pharmacology and molecular simulation study on the multi-target gene regulatory mechanism of Isatis indigotica against hepatic inflammation. PloS one · 13 Aug 2026 PMID 42594138
  4. Integrated UPLC-MS/MS profiling and network pharmacology-based analysis of the anti-hyperglycemic potential of Baihu Jia Renshen Decoction combined with Sanghuangporus vaninii extract in mice. Journal of molecular histology · 1 Aug 2026 PMID 42541619
  5. The Predictive Value of Tenascin-C, Neopterin and Pro-Inflammatory Cytokines (IFN-γ, TNF-α, IL-6) in Alcohol Use Disorder Treatment Response. Addiction biology · 24 Jul 2026 PMID 42494139
  6. Network pharmacology-guided discovery of quercetin as an anti-osteoporotic agent from cyathulae radix with dual pro-osteogenic and antioxidant effects. Molecular biology reports · 20 Jul 2026 PMID 42474720
  7. Clinical investigation of plasma HIF-1α and inflammatory biomarkers in dogs with thoracolumbar intervertebral disc disease receiving acupuncture treatment. Veterinary research communications · 29 Jun 2026 PMID 42371222
  8. Targeting the gut-ovarian axis: Scutellaria baicalensis improves polycystic ovary syndrome by modulating gut microbiota composition and inhibiting the LPS/TLR4/NF-κB signaling pathway. mSystems · 15 Jun 2026 PMID 42294648
Inflammatory Cytokine Profiling (8)
  1. Calcitriol, the active form of vitamin D, induces cell death and purinergic signaling modulation in cutaneous melanoma cells. Medical oncology (Northwood, London, England) · 15 Sept 2026 PMID 42742798
  2. Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human cell · 2 Sept 2026 PMID 42684559
  3. Hypoxia-Driven Mechanisms in Ischemic Heart Failure: A Bioinformatics, Machine Learning and Bayesian Network Study. Cardiovascular toxicology · 26 Aug 2026 PMID 42645701
  4. A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis. Inflammation · 26 Jun 2026 PMID 42360398
  5. Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels. Cancer prevention research (Philadelphia, Pa.) · 18 Jun 2026 PMID 42310898
  6. IL-6 Activity is Required for Maximal Catecholamine Release During High-Intensity Exercise in Men. Molecular metabolism · 10 Jun 2026 PMID 42270042
  7. Integrating machine learning and WGCNA to identify core candidate genes and decipher immune-related molecular networks in TcdA/TcdB-associated CDI. Antonie van Leeuwenhoek · 2 Jun 2026 PMID 42230843
  8. Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension. Brain research · 29 May 2026 PMID 42214536
IL-6 Biomarker Prediction (7)
  1. DyAb: sequence-based antibody design and property prediction in a low-data regime. mAbs · 28 Aug 2026 PMID 42665538
  2. Interleukin-6 as a sepsis biomarker in neonatal and pediatric care: A retrospective real world cohort study. European journal of pediatrics · 20 Aug 2026 PMID 42622709
  3. The diagnostic value of interleukin-6, procalcitonin, and C-reactive protein in the severity of acute appendicitis in children. Pediatric surgery international · 19 Aug 2026 PMID 42616153
  4. IL-6 Upregulates CD73 in Human Placental Mesenchymal Stem Cells to Promote ATRA-Induced NB4 Cell Differentiation in Acute Promyelocytic Leukemia. Cancer medicine · 30 Jul 2026 PMID 42528120
  5. Early Diagnosis and Longitudinal Monitoring of Myocardial Infarction in Tuberculosis Patients with High-Throughput Suspension Array Testing of a Biomarker Panel. Analytical chemistry · 18 Jun 2026 PMID 42314097
  6. Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis. Journal of the American College of Cardiology · 3 Jun 2026 PMID 42233927
  7. The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC). Journal of the American College of Cardiology · 27 May 2026 PMID 42201287
Targeting IL-6 Inflammation (3)
  1. IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer. Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 18 Oct 2026 PMID 42892641
  2. A Dual-Membrane Biomimetic Nanoplatform Enables Triple-Modal Therapy Against SARS-CoV-2 Through Viral Decoy, Inflammation Neutralizing, and Intracellular RNAi. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 7 Sept 2026 PMID 42702867
  3. Discovery of CDK8/19 inhibitors as lead compounds for IL-6-dependent lymphoma enabled by the formal synthesis of cortistatin A. Science advances · 4 Sept 2026 PMID 42696577

By study type

Clinical trials (2)
  1. Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels. Cancer prevention research (Philadelphia, Pa.) · 18 Jun 2026 PMID 42310898
  2. Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis. Journal of the American College of Cardiology · 3 Jun 2026 PMID 42233927
Observational studies and case reports (8)
  1. Evaluation of the Role of Interleukin 6 in Paget's Disease of Bone. Calcified tissue international · 3 Sept 2026 PMID 42687003
  2. Interleukin-6 as a sepsis biomarker in neonatal and pediatric care: A retrospective real world cohort study. European journal of pediatrics · 20 Aug 2026 PMID 42622709
  3. The diagnostic value of interleukin-6, procalcitonin, and C-reactive protein in the severity of acute appendicitis in children. Pediatric surgery international · 19 Aug 2026 PMID 42616153
  4. The Predictive Value of Tenascin-C, Neopterin and Pro-Inflammatory Cytokines (IFN-γ, TNF-α, IL-6) in Alcohol Use Disorder Treatment Response. Addiction biology · 24 Jul 2026 PMID 42494139
  5. A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis. Inflammation · 26 Jun 2026 PMID 42360398
  6. Early Diagnosis and Longitudinal Monitoring of Myocardial Infarction in Tuberculosis Patients with High-Throughput Suspension Array Testing of a Biomarker Panel. Analytical chemistry · 18 Jun 2026 PMID 42314097
  7. Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension. Brain research · 29 May 2026 PMID 42214536
  8. The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC). Journal of the American College of Cardiology · 27 May 2026 PMID 42201287
Human data, design not indexed (6)
  1. IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer. Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 18 Oct 2026 PMID 42892641
  2. Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human cell · 2 Sept 2026 PMID 42684559
  3. DyAb: sequence-based antibody design and property prediction in a low-data regime. mAbs · 28 Aug 2026 PMID 42665538
  4. Network pharmacology and molecular simulation study on the multi-target gene regulatory mechanism of Isatis indigotica against hepatic inflammation. PloS one · 13 Aug 2026 PMID 42594138
  5. IL-6 Activity is Required for Maximal Catecholamine Release During High-Intensity Exercise in Men. Molecular metabolism · 10 Jun 2026 PMID 42270042
  6. Integrating machine learning and WGCNA to identify core candidate genes and decipher immune-related molecular networks in TcdA/TcdB-associated CDI. Antonie van Leeuwenhoek · 2 Jun 2026 PMID 42230843
Preclinical: animal, cell and lab studies (9)
  1. Calcitriol, the active form of vitamin D, induces cell death and purinergic signaling modulation in cutaneous melanoma cells. Medical oncology (Northwood, London, England) · 15 Sept 2026 PMID 42742798
  2. Discovery of CDK8/19 inhibitors as lead compounds for IL-6-dependent lymphoma enabled by the formal synthesis of cortistatin A. Science advances · 4 Sept 2026 PMID 42696577
  3. Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
  4. Hypoxia-Driven Mechanisms in Ischemic Heart Failure: A Bioinformatics, Machine Learning and Bayesian Network Study. Cardiovascular toxicology · 26 Aug 2026 PMID 42645701
  5. Integrated UPLC-MS/MS profiling and network pharmacology-based analysis of the anti-hyperglycemic potential of Baihu Jia Renshen Decoction combined with Sanghuangporus vaninii extract in mice. Journal of molecular histology · 1 Aug 2026 PMID 42541619
  6. IL-6 Upregulates CD73 in Human Placental Mesenchymal Stem Cells to Promote ATRA-Induced NB4 Cell Differentiation in Acute Promyelocytic Leukemia. Cancer medicine · 30 Jul 2026 PMID 42528120
  7. Network pharmacology-guided discovery of quercetin as an anti-osteoporotic agent from cyathulae radix with dual pro-osteogenic and antioxidant effects. Molecular biology reports · 20 Jul 2026 PMID 42474720
  8. Clinical investigation of plasma HIF-1α and inflammatory biomarkers in dogs with thoracolumbar intervertebral disc disease receiving acupuncture treatment. Veterinary research communications · 29 Jun 2026 PMID 42371222
  9. Targeting the gut-ovarian axis: Scutellaria baicalensis improves polycystic ovary syndrome by modulating gut microbiota composition and inhibiting the LPS/TLR4/NF-κB signaling pathway. mSystems · 15 Jun 2026 PMID 42294648
Unclassified: not yet indexed with MeSH (1)
  1. A Dual-Membrane Biomimetic Nanoplatform Enables Triple-Modal Therapy Against SARS-CoV-2 Through Viral Decoy, Inflammation Neutralizing, and Intracellular RNAi. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 7 Sept 2026 PMID 42702867